Events Updates for the Psychedelics Industry

Psychedelics News

Events

19 Apr 2022

PsyCap Recap: Origin Therapeutics

Alfred Wong, Vice President of Investments for Origin, joined last month’s Psychedelic Capital event....

By Microdose

Events, Industry

18 Apr 2022

PsyCap Recap: Clearmind Medicine

With dozens of companies racing to drive classic psychedelics through clinical trials, or spending years and untold millions developing next-generation versions of these well-known molecules, Clearmind could have its own...

By Microdose

Events

17 Mar 2022

LSD Conference Recap: IMIO Life

Dr....

By Microdose

Events

16 Mar 2022

LSD Conference Recap: MindBio Therapeutics

MindBio co-founder Justin Hanka kicked off the conference with a presentation during the “Emerging Treatments in Mental Health” panel....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Events

15 Feb 2022

PsyCap Recap Jan 2022: Entheo Digital

Entheo Digital is working to position itself as a leading innovator in this space....

By Microdose

Events

15 Feb 2022

PsyCap Recap: HAVN Life Sciences

HAVN Life CEO Tim Moore and Spore Life CEO Michael Zavet joined Microdose’s Patrick Moher at the recent Psychedelic Capital event...

By Microdose

Events

20 Jan 2022

The LSD Conference: A Molecular Masterclass – Call for Speakers

Microdose Psychedelic Insights (“Microdose”), your guide to the business of psychedelics, in partnership with MindBio Therapeutics a clinical-stage drug development company conducting research into microdosing and medicinal use of psychedelic...

By Microdose

Events

6 Jan 2022

PsyCap Recap: Zeifmans

Rounding out the coverage from Microdose's last Psychedelic Capital event, a roundtable discussion with some of the industry’s top minds, giving insights into a variety of topics....

By Microdose

Events

27 Dec 2021

PsyCap Recap: KGK Science Helps Navigate Psychedelic Product Development

KGK Science is a full-service contract research organization (CRO) supporting the nutraceutical, cannabis and psychedelic industries....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result